All data are based on the daily closing price as of December 24, 2024
h
Hanmi Science Co.
008930.KO
19.91 USD
-0.18
-0.90%
Overview
Last close
19.91 usd
Market cap
1.35B usd
52 week high
41.97 usd
52 week low
19.60 usd
Target price
22.19 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
1.5536
Price/Book Value
2.3487
Enterprise Value
1.46B usd
EV/Revenue
1.6639
EV/EBITDA
15.0676
Key financials
Revenue TTM
870.72M usd
Gross Profit TTM
89.84M usd
EBITDA TTM
40.09M usd
Earnings per Share
N/A usd
Dividend
0.21 usd
Total assets
1,267.32B usd
Net debt
N/A usd
About
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition, it offers automated drug management systems. The company sells its products through online and offline pharmacies. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is headquartered in Seoul, South Korea.